GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Supriya Lifescience Ltd (BOM:543434) » Definitions » Equity-to-Asset

Supriya Lifescience (BOM:543434) Equity-to-Asset : 0.89 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Supriya Lifescience Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Supriya Lifescience's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹8,154 Mil. Supriya Lifescience's Total Assets for the quarter that ended in Mar. 2024 was ₹9,212 Mil. Therefore, Supriya Lifescience's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.89.

The historical rank and industry rank for Supriya Lifescience's Equity-to-Asset or its related term are showing as below:

BOM:543434' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.37   Med: 0.72   Max: 0.89
Current: 0.89

During the past 6 years, the highest Equity to Asset Ratio of Supriya Lifescience was 0.89. The lowest was 0.37. And the median was 0.72.

BOM:543434's Equity-to-Asset is ranked better than
83.48% of 1556 companies
in the Biotechnology industry
Industry Median: 0.67 vs BOM:543434: 0.89

Supriya Lifescience Equity-to-Asset Historical Data

The historical data trend for Supriya Lifescience's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Supriya Lifescience Equity-to-Asset Chart

Supriya Lifescience Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Equity-to-Asset
Get a 7-Day Free Trial 0.44 0.60 0.84 0.85 0.89

Supriya Lifescience Quarterly Data
Mar19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 - 0.89 - 0.89

Competitive Comparison of Supriya Lifescience's Equity-to-Asset

For the Biotechnology subindustry, Supriya Lifescience's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Supriya Lifescience's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Supriya Lifescience's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Supriya Lifescience's Equity-to-Asset falls into.



Supriya Lifescience Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Supriya Lifescience's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=8153.67/9212.38
=0.89

Supriya Lifescience's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=8153.67/9212.38
=0.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Supriya Lifescience  (BOM:543434) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Supriya Lifescience Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Supriya Lifescience's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Supriya Lifescience (BOM:543434) Business Description

Traded in Other Exchanges
Address
Sonawala Road, 207/208, Udyog Bhavan, Goregaon East, Mumbai, MH, IND, 400063
Supriya Lifescience Ltd is a manufacturer of Active pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.

Supriya Lifescience (BOM:543434) Headlines

No Headlines